Infectious Disorders - Drug TargetsInfectious Disorders - Drug TargetsInfectious Disorders - Drug Targets1871-52652212-3989Bentham Science64558310.2174/0118715265259959231031104820MedicineResearch ArticleTriple Burden: The Incorrigible Threat of Tuberculosis, HIV, and COVID-19GuptaParakritiinfo@benthamscience.netSandhuDiljotinfo@benthamscience.netGuptaVarshainfo@benthamscience.netSinghalLipikainfo@benthamscience.netDepartment of Microbiology, Government Medical College and HospitalDepartment of Microbiology, GMCH0104202424411012025Copyright ©; 2024, Bentham Science Publishers2024Bentham Science Publishershttps://journals.eco-vector.com/1871-5265/article/view/645583

The Coronavirus-19 (COVID-19) hasn’t seen the dawn since its emergence, however waxing and waning has resulted in the emergence of deadly variants. The effects of pandemic have not been limited to its virulence, but have rather conferred multiple collateral effects, especially in developing countries; thereby, designating it as a SYNDEMIC. The same culminated in neglect of non-COVID-19 conditions like tuberculosis (TB) and human immunodeficiency virus-acquired immunodeficiency syndrome (HIV/AIDS). Besides being the prognostic factor for severe COVID-19, these infections in hidden pockets served as reservoir for emergence of the deadly Omicron. Another significant impact of this juxtaposition was on the delivery of healthcare services for TB and HIV.

2:The unanticipated COVID-19 pandemic turned the path of ongoing progress of elimination programs. Direct consequences of the COVID-19 pandemic were pronounced on diagnosis, treatment, and services for patients with TB and HIV. Essential TB services were reallocated to the COVID-19 rapid response task force. However, despite escalating the tribulations, this triple burden has simultaneously taught lessons to escalate the progress of halted programs. The pandemic has catalyzed an unusual level of collaboration among scientists, which can be exploited for TB and HIV. Fast-track diagnostics, digitalization, contact tracing, and vaccine development have enabled world to envision the same for TB/HIV.

COVID-19pandemictuberculosisHIV/AIDSmanagementDOTS.WHO Statement Regarding Cluster of Pneumonia Cases in Wuhan, China. Available from: https://www.who.int/china/news/detail/09-01-2020-who-statement-regarding-cluster-of-pneumonia-cases-in-wuhan-chinaTracking SARS-CoV-2 variants. Available from: https://www.who.int/activities/tracking-SARS-CoV-2-variantsCourtin E, Vineis P. COVID-19 as a syndemic. Front Public Health 2021; 9763830. doi: 10.3389/fpubh.2021.763830 PMID: 34568273Piketty J, Carbonnel M, Murtada R, et al. Collateral damage of COVID-19 pandemic: The impact on a gynecologic surgery department. J Gynecol Obstet Hum Reprod 2022; 51(1): 102255. doi: 10.1016/j.jogoh.2021.102255 PMID: 34757223Thiagarajan K. Covid-19 exposes the high cost of India’s reliance on private healthcare. BMJ 2020; 370: m3506. doi: 10.1136/bmj.m3506 PMID: 32912849Tamuzi JL, Ayele BT, Shumba CS, et al. Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence. BMC Infect Dis 2020; 20(1): 744. doi: 10.1186/s12879-020-05450-4 PMID: 33036570The Connection between TB and HIV ⋅ Pamphlets, Brochures, Booklets⋅Publications & Products ⋅ TB ⋅ CDC. 2022. Available from: https://www.cdc.gov/tb/publications/pamphlets/tbandhiv_eng.htmWaters R, Ndengane M, Abrahams MR, Diedrich CR, Wilkinson RJ, Coussens AK. The Mtb -HIV syndemic interaction: Why treating M. tuberculosis infection may be crucial for HIV-1 eradication. Future Virol 2020; 15(2): 101-26. doi: 10.2217/fvl-2019-0069 PMID: 32273900Ssentongo P, Ssentongo AE, Heilbrunn ES, Du P. 393. Prevalence of HIV in patients hospitalized for COVID-19 and associated mortality outcomes: A systematic review and meta-analysis. Open Forum Infect Dis 2020; 7(S1): S266. doi: 10.1093/ofid/ofaa439.588Nachega JB, Kapata N, Sam-Agudu NA, et al. Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa. Int J Infect Dis 2021; 113(S1): S16-21. doi: 10.1016/j.ijid.2021.03.038 PMID: 33757874Karim SSA, Churchyard GJ, Karim QA, Lawn SD. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet 2009; 374(9693): 921-33. doi: 10.1016/S0140-6736(09)60916-8 PMID: 19709731Khandia R, Singhal S, Alqahtani T, et al. Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic. Environ Res 2022; 209112816. doi: 10.1016/j.envres.2022.112816 PMID: 35093310Freer J, Mudaly V. HIV and covid-19 in South Africa BMJ 2022; 376e069807 doi: 10.1136/bmj-2021-069807 PMID: 35086921Brumme ZL, Mwimanzi F, Lapointe HR, et al. Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy. medRxiv 2021; 2021.10.03.21264320. doi: 10.1101/2021.10.03.21264320Coronavirus disease (COVID-19) and people living with HIV. Available from:. https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-covid-19-and-people-living-with-hivLogunov DY, Livermore DM, Ornelles DA, et al. COVID-19 vaccination and HIV-1 acquisition. Lancet 2022; 399(10333): e34-5. doi: 10.1016/S0140-6736(22)00332-4 PMID: 35397866Chun HM, Milligan K, Agyemang E, et al. A systematic review of COVID-19 vaccine antibody responses in people with HIV. Open Forum Infect Dis 2022; 9(11): ofac579. doi: 10.1093/ofid/ofac579 PMID: 36438620Hassold N, Brichler S, Ouedraogo E, et al. Impaired antibody response to COVID-19 vaccination in advanced HIV infection. AIDS 2022; 36(4): F1-5. doi: 10.1097/QAD.0000000000003166 PMID: 35013085Hogan AB, Jewell BL, Sherrard-Smith E, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: A modelling study. Lancet Glob Health 2020; 8(9): e1132-41. doi: 10.1016/S2214-109X(20)30288-6 PMID: 32673577Global Fund Results Report Reveals COVID-19 Devastating Impact on HIV, TB and Malaria Programs. Available from: https://www.theglobalfund.org/en/news/2021/2021-09-08-global-fund-results-report-reveals-covid-19-devastating-impact-on-hiv-tb-and-malaria-programs/Can Sarınoğllu R, Sili U, Eryuksel E, Olgun Yildizeli S, Cimsit C, Karahasan Yagci A. Tuberculosis and COVID-19: An overlapping situation during pandemic. J Infect Dev Ctries 2020; 14(7): 721-5. doi: 10.3855/jidc.13152 PMID: 32794460Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic. Available from: https://www.who.int/news/item/14-10-2021-tuberculosis-deaths-rise-for-the-first-time-in-more-than-a-decade-due-to-the-covid-19-pandemicOn World TB day WHO calls for increased investments into TB services and research. Available from: https://www.who.int/news/item/21-03-2022-on-world-tb-day-who-calls-for-increased-investments-into-tb-services-and-researchPerween R. PraveenKumar M, Shrivastava T, et al. The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41. Int Immunopharmacol 2021; 101(Pt B): 108187. doi: 10.1016/j.intimp.2021.108187 PMID: 34649114Silver ZA, Antonopoulos A, Haslam SM, et al. Discovery of o-linked carbohydrate on HIV-1 envelope and its role in shielding against one category of broadly neutralizing antibodies. Cell Rep 2020; 30(6): 1862-1869.e4. doi: 10.1016/j.celrep.2020.01.056 PMID: 32049016Mishra N, Kumar S, Singh S, et al. Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma. PLoS Pathog 2021; 17(9): e1009958. doi: 10.1371/journal.ppat.1009958 PMID: 34559854Global tuberculosis report 2020. Available from:. https://www.who.int/publications-detail-redirect/9789240013131CDC announces Think. Test. Treat TB: a campaign to raise awareness of latent TB infection ⋅ Dear Colleague Letters ⋅ TB ⋅ CDC. Available from: https://www.cdc.gov/tb/publications/letters/2022/tb-campaign.htmlTB & COVID-19. Available from:. https://www.who.int/teams/global-tuberculosis-programme/covid-19Mousquer GT, Peres A, Fiegenbaum M. Pathology of TB/COVID-19 Co-Infection: The phantom menace. Tuberculosis 2021; 126102020. doi: 10.1016/j.tube.2020.102020 PMID: 33246269The End TB Strategy. Available from:. https://www.who.int/teams/global-tuberculosis-programme/the-end-tb-strategyStates and UTs accelerate action to end TB by 2025. Available from:. https://www.who.int/india/news/detail/09-11-2021-states-and-uts-accelerate-action-to-end-tb-by-2025Cilloni L, Fu H, Vesga JF, et al. The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis. EClinicalMedicine 2020; 28100603. doi: 10.1016/j.eclinm.2020.100603 PMID: 33134905WHO Global TB progress at risk Available from: https://www.who.int/news/item/14-10-2020-who-global-tb-progress-at-riskEnd TB. The clock is ticking ⋅ World Economic Forum. Available from:. https://www.weforum.org/agenda/2021/03/end-tb-the-clock-is-ticking/Shrinivasan R, Rane S, Pai M. India’s syndemic of tuberculosis and COVID-19. BMJ Glob Health 2020; 5(11): e003979. doi: 10.1136/bmjgh-2020-003979 PMID: 33199280Tuberculosis and COVID-19 ⋅ Stop TB Partnership. Available from: . https://www.stoptb.org/covid19The impact of COVID-19 on HIV, TB and malaria services and systems for health - Updates - The Global Fund to Fight AIDS, Tuberculosis and Malaria. Available from: https://www.theglobalfund.org/en/updates/2021/2021-04-13-the-impact-of-covid-19-on-hiv-tb-and-malaria-services-and-systems-for-health/HMIS-Health Management Information System. Available from:. https://hmis.nhp.gov.in/#!/aboutusChatterjee P. Is India missing COVID-19 deaths? Lancet 2020; 396(10252): 657. doi: 10.1016/S0140-6736(20)31857-2 PMID: 32891197Unite To Fight. Available from:. https://www.theglobalfund.org/en/unite-to-fight/Directives regarding TB services during Covid19 emergency period :: Central TB Division. Available from: https://tbcindia.gov.in/index1.php?lang=1&level=1&sublinkid=5428&lid=3509Pai M. Tuberculosis And Covid-19: Fighting A Deadly Syndemic. Forbes. Available from: https://www.forbes.com/sites/madhukarpai/2020/09/26/tuberculosis-and-covid-19-fighting-a-deadly-syndemic/How Covid is making it tougher to tackle TB, AIDS, malaria and child health. Available from: https://theprint.in/health/how-covid-is-making-it-tougher-to-tackle-tb-aids-malaria-and-child-health/443658/Technical guidance. Available from: https://www.who.int/india/home/emergencies/ongoing-disease-outbreak-disasters/technical-guidanceCoronavirus disease (COVID-19): HIV and antiretrovirals. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-hiv-and-antiretroviralsAn S, Li Y, Lin Y, et al. Genome-wide profiling reveals alternative polyadenylation of innate immune-related mRNA in patients with COVID-19. Front Immunol 2021; 12756288. doi: 10.3389/fimmu.2021.756288 PMID: 34777369Chen Y, Wang G, Li J, et al. CASA: A comprehensive database resource for the COVID-19 Alternative splicing atlas. J Transl Med 2022; 20(1): 473. doi: 10.1186/s12967-022-03699-8 PMID: 36266726An S, Xie Z, Liao Y, et al. Systematic analysis of clinical relevance and molecular characterization of m6A in COVID-19 patients. Genes Dis 2022; 9(5): 1170-3. doi: 10.1016/j.gendis.2021.12.005 PMID: 35013711Joy M, Malavika B, Asirvatham ES, Sudarsanam TD, Jeyaseelan L. Is BCG associated with reduced incidence of COVID-19? A meta-regression of global data from 160 countries. Clin Epidemiol Glob Health 2021; 9: 202-3. doi: 10.1016/j.cegh.2020.08.015 PMID: 33163696Gong W, Mao Y, Li Y, Qi Y. BCG vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents. Int Immunopharmacol 2022; 108108870. doi: 10.1016/j.intimp.2022.108870 PMID: 35597119Glynn JR, Dube A, Fielding K, Crampin AC, Kanjala C, Fine PEM. The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi. Lancet Infect Dis 2021; (21)11: 1590-7. doi: 10.1016/S1473-3099(20)30994-4 PMID: 34237262COVID-19 Strategic Preparedness and Response Plan Operational Planning Guideline. Available from: https://www.who.int/publications/m/item/covid-19-strategicpreparedness-and-response-plan-operational-planning-guideline